Riittävä lihasmassa ja aerobinen kunto eliniän pidentäjinä lihaskadossa
Main funder
Funder's project number: 275922
Funds granted by main funder (€)
- 484 485,00
Funding program
Project timetable
Project start date: 01/09/2014
Project end date: 31/08/2019
Principal Investigator
Other persons related to this project (JYU)
Primary responsible unit
Related publications and other outputs
- Substantial Fat Loss in Physique Competitors Is Characterized by Increased Levels of Bile Acids, Very-Long Chain Fatty Acids, and Oxylipins (2022) Sarin, Heikki V.; et al.; A1; OA
- Higher glucose availability augments the metabolic responses of the C2C12 myotubes to exercise-like electrical pulse stimulation (2021) Lautaoja, Juulia H.; et al.; A1; OA
- Mitochondrial bioenergetic pathways in blood leukocyte transcriptome decrease after intensive weight loss but are rescued following weight regain in female physique athletes (2021) Sarin, Heikki V.; et al.; A1; OA
- Muscle follistatin gene delivery increases muscle protein synthesis independent of periodical physical inactivity and fasting (2021) Nissinen, Tuuli A.; et al.; A1; OA
- Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments (2021) Hulmi, Juha J.; et al.; A2; OA
- Differentiation of Murine C2C12 Myoblasts Strongly Reduces the Effects of Myostatin on Intracellular Signaling (2020) Lautaoja, Juulia H.; et al.; A1; OA
- Muscle NAD+ depletion and Serpina3n as molecular determinants of murine cancer cachexia : the effects of blocking myostatin and activins (2020) Hulmi, J.; et al.; A1; OA
- Sprint and Strength Training Modulates Autophagy and Proteostasis in Aging Sprinters (2020) Hentilä, Jaakko; et al.; A1; OA
- Systemic Blockade of ACVR2B Ligands Attenuates Muscle Wasting in Ischemic Heart Failure Without Compromising Cardiac Function (2020) Szabó, Zoltán; et al.; A1; OA
- Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and Liver (2019) Hentilä, Jaakko; et al.; A1; OA